Uridin-2',3',5'-triacetat
|
|
- CAS-Nr.
- 4105-38-8
- Bezeichnung:
- Uridin-2',3',5'-triacetat
- Englisch Name:
- 2',3',5'-Tri-O-acetyluridine
- Synonyma:
- TAU;Uridine triacetate;(2R,3R,4R,5R)-2-(AcetoxyMethyl)-5-(2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate;MTBT1;MAPTL;RG 2133;Vistonuridine;2',3',5'-TriacetyL;Tri-O-acetyl uridine;2',3',5'-Tri-O-acety
- CBNumber:
- CB0687805
- Summenformel:
- C15H18N2O9
- Molgewicht:
- 370.31
- MOL-Datei:
- 4105-38-8.mol
|
Uridin-2',3',5'-triacetat Eigenschaften
- Schmelzpunkt:
- 127.0 to 131.0 °C
- Dichte
- 1.43±0.1 g/cm3(Predicted)
- storage temp.
- Inert atmosphere,Store in freezer, under -20°C
- Löslichkeit
- Chloroform (Slightly), Dichloromethane (Slightly), DMSO (Slightly)
- Aggregatzustand
- Solid
- pka
- 9.39±0.10(Predicted)
- Farbe
- Off-White
- InChI
- InChI=1S/C15H18N2O9/c1-7(18)23-6-10-12(24-8(2)19)13(25-9(3)20)14(26-10)17-5-4-11(21)16-15(17)22/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,22)/t10-,12-,13-,14-/m1/s1
- InChIKey
- AUFUWRKPQLGTGF-QRMSVCKNSA-N
- SMILES
- C(OC(=O)C)[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@H](OC(=O)C)[C@@H]1OC(=O)C
- CAS Datenbank
- 4105-38-8(CAS DataBase Reference)
Sicherheit
S-Sätze: |
24/25 |
|
|
WGK Germany |
3 |
|
|
HS Code |
29349990 |
|
|
Uridin-2',3',5'-triacetat Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Uridine
triacetate is an orally available pro-drug of uridine approved by
the FDA for the treatment of the rare autosomal recessive
disorder called hereditary orotic aciduria. The drug was also
approved for treating overdose of two chemotherapies
(fluorouracil and capecitabine). Uridine triacetate was
developed by Wellstat Therapeutics and licensed to BTG.
Chemische Eigenschaften
White or almost white crystalline powder
Verwenden
2’,3’,5’-Triacetyluridine is used in the treatment of Alzheimer’s disease in mice and provide neuroprotective effects. Shown to also decrease depressive symptoms and increases in brain pH bipolar patients.
Definition
ChEBI: Uridine triacetate is an acetate ester that is uracil in which the three hydroxy hydrogens are replaced by acetate group. A prodrug for uridine, it is used for the treatment of hereditary orotic aciduria and for management of fluorouracil toxicity. It has a role as a prodrug, a neuroprotective agent and an orphan drug. It is a member of uridines and an acetate ester.
Uridin-2',3',5'-triacetat Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Uridin-2',3',5'-triacetat Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 300)Lieferanten
4105-38-8(Uridin-2',3',5'-triacetat)Verwandte Suche:
- 2'', 3'', 5''-TRIACETYLURIDINE (2'', 3'', 5''-TRI-O-ACETYLURIDINE)
- RG 2133
- Tri-O-acetyl uridine
- Vistonuridine
- 1-((2R,3R,4R,5R)-3,4-Diacetyl-3,4-dihydroxy-5-(1-hydroxy-2-oxopropyl)tetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione
- 2',3',5'-Tri-O-acetyl-rU
- 1-((2R,3R,4R,5R)-3,4-Diacetyl-3,4-dihydroxy-5-(1-hydroxy-2-oxopropyl)tetrahydrofuran-2-yl)pyrimid
- ANTI-TAU(C-TERMINAL) antibody produced in rabbit
- MAPTL
- Microtubule-associated protein tau
- MTBT1
- ANTI-TAU (MAPT) (S720) antibody produced in rabbit
- [4-acetoxy-2-(acetoxymethyl)-5-(2,4-dioxopyrimidin-1-yl)tetrahydrofuran-3-yl] acetate
- [4-acetyloxy-2-(acetyloxymethyl)-5-(
- [4-acetyloxy-2-(acetyloxymethyl)-5-(2,4-dioxopyrimidin-1-yl)oxolan-3-yl] acetate
- 2-(acetoxymethyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate
- 2-[(acetyloxy)methyl]-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate
- acetic acid [4-acetoxy-2-(acetoxymethyl)-5-(2,4-diketopyrimidin-1-yl)tetrahydrofuran-3-yl] ester
- acetic acid [4-acetoxy-2-(acetoxymethyl)-5-(2,4-dioxo-1-pyrimidinyl)-3-tetrahydrofuranyl] ester
- 1-((2R,3R,4R,5R)-3,4-Diacetyl-3,4-dihydroxy-5-(1-hydroxy-2-oxopropyl)tetrahydrofuran-2-yl)pyri
- (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4
- 2',3',5'-tri-O-Acetyluridine≥ 98% (HPLC)
- URIDINE 2',3',5'-TRIACETATE
- 2',3',5'-TRI-O-ACETYLURIDINE
- 2',3',5'-TRIACETYLURIDINE
- 1-(2-O,3-O,5-O-Triacetyl-β-D-ribofuranosyl)-4-hydroxypyrimidine-2(1H)-one
- [(2R,3R,4R,5R)-4-acetyloxy-2-(acetyloxymethyl)-5-(2,4-dioxopyrimidin-1-yl)oxolan-3-yl] acetate
- [(2R,3R,4R,5R)-4-acetyloxy-2-(acetyloxymethyl)-5-(2,4-dioxopyrimidin-1-yl)oxolan-3-yl] ethanoate
- acetic acid [(2R,3R,4R,5R)-4-acetoxy-2-(acetoxymethyl)-5-(2,4-diketopyrimidin-1-yl)tetrahydrofuran-3-yl] ester
- 2',3',5'-Tri-O-acety
- [(2S,3R,4S,5S)-3,4-bis(acetyloxy)-5-(2,4-dioxo-1,2,3,4-tetrahydropyriMidin-1-yl)oxolan-2-yl]Methyl acetate
- 2',3',5'-Tri0acetyluridine
- 2`,3`,5`-Tracetyluridine
- 2',3',5'-Tri-O-acetyl-D-uridine
- (Ser232) BioAssay&trade
- Phospho-14-3-3 &theta
- phosphorylated (S232)
- 2',3',5'-TriacetyL
- 2',3',5'-Tri-O-acetyluridine USP/EP/BP
- Uridine triacetate
- (2R,3R,4R,5R)-2-(AcetoxyMethyl)-5-(2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate
- TAU
- Mouse Anti-Tau antibody
- 2',3',5'-Tri-O-acetyluridine
- 4105-38-8
- 4105-38-3
- C15H18N2O9
- Biochemicals and Reagents
- BioChemical
- Nucleoside Analogs
- Nucleosides, Nucleotides, Oligonucleotides